GB2209668B - Oral, sustained-release composition comprising potassium and magnesium - Google Patents

Oral, sustained-release composition comprising potassium and magnesium

Info

Publication number
GB2209668B
GB2209668B GB8821056A GB8821056A GB2209668B GB 2209668 B GB2209668 B GB 2209668B GB 8821056 A GB8821056 A GB 8821056A GB 8821056 A GB8821056 A GB 8821056A GB 2209668 B GB2209668 B GB 2209668B
Authority
GB
United Kingdom
Prior art keywords
sustained
oral
magnesium
potassium
release composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8821056A
Other languages
English (en)
Other versions
GB2209668A (en
GB8821056D0 (en
Inventor
Pravin Bhagzanji Sheth
Frederick John Dechow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB8821056D0 publication Critical patent/GB8821056D0/en
Publication of GB2209668A publication Critical patent/GB2209668A/en
Application granted granted Critical
Publication of GB2209668B publication Critical patent/GB2209668B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB8821056A 1987-09-11 1988-09-08 Oral, sustained-release composition comprising potassium and magnesium Expired - Lifetime GB2209668B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11

Publications (3)

Publication Number Publication Date
GB8821056D0 GB8821056D0 (en) 1988-10-05
GB2209668A GB2209668A (en) 1989-05-24
GB2209668B true GB2209668B (en) 1991-06-05

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8821056A Expired - Lifetime GB2209668B (en) 1987-09-11 1988-09-08 Oral, sustained-release composition comprising potassium and magnesium

Country Status (12)

Country Link
JP (1) JPH01100128A (fr)
AU (1) AU619481B2 (fr)
BE (1) BE1001842A3 (fr)
CH (1) CH677612A5 (fr)
DE (1) DE3830563A1 (fr)
DK (1) DK501288A (fr)
FR (1) FR2620334A1 (fr)
GB (1) GB2209668B (fr)
IT (1) IT1227010B (fr)
LU (1) LU87331A1 (fr)
NL (1) NL8802224A (fr)
SE (1) SE8803125L (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (fr) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Composition d'apport de potassium
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (fi) * 1991-03-01 1992-09-02 Slk Marketing Oy Dryckpulver.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
CN1090483C (zh) * 1997-07-31 2002-09-11 谢理峰 钾镁缓释片及生产方法
DE10158286B4 (de) * 2000-11-20 2007-08-02 Dehn, Michael C. Wirkstoffspeicherndes Schichtmaterial
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
ATE485814T1 (de) * 2005-08-19 2010-11-15 Verla Pharm Magnesium-mikrotabletten mit verzögerter freisetzung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356097A (en) * 1972-02-25 1974-06-12 Hoffmann La Roche Mineral salt preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356097A (en) * 1972-02-25 1974-06-12 Hoffmann La Roche Mineral salt preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
AU619481B2 (en) 1992-01-30
LU87331A1 (fr) 1989-10-26
GB2209668A (en) 1989-05-24
DK501288D0 (da) 1988-09-09
BE1001842A3 (fr) 1990-03-20
DK501288A (da) 1989-03-12
DE3830563A1 (de) 1989-03-30
IT1227010B (it) 1991-03-05
SE8803125D0 (sv) 1988-09-06
CH677612A5 (fr) 1991-06-14
AU2204388A (en) 1989-03-16
SE8803125L (sv) 1989-03-12
IT8848327A0 (it) 1988-09-08
GB8821056D0 (en) 1988-10-05
FR2620334A1 (fr) 1989-03-17
JPH01100128A (ja) 1989-04-18
NL8802224A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
NZ225101A (en) Sustained release composition
GB2211206B (en) Alloys
AR243378A1 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion prolongada.
EP0283257A3 (en) Edible composition
GB8721936D0 (en) Composition
JPS6429465A (en) Highly heat-resistant inorgnaic composition
EP0371542A3 (en) Oral composition
EP0310372A3 (en) Dental composition
ZA88637B (en) Fire-resitant composition
EP0292963A3 (en) Fiber-treatment composition
GB8804113D0 (en) Composition
EP0311260A3 (en) Oral compositions
PH25789A (en) Oral composition
JPS6470458A (en) Alkylaminoalkoxyphenyl derivative, manufacture and composition
GB8713040D0 (en) Oral compositions
JPS6479146A (en) Drug composition
AU3089589A (en) Magnesium potassium citrate
GB2209668B (en) Oral, sustained-release composition comprising potassium and magnesium
HUT51856A (en) Mollusquicid composition
GB8715191D0 (en) Composition
EG18594A (en) Shampo composition
GB8724544D0 (en) Oral compositions
GB8723116D0 (en) Oral compositions
EP0335982A4 (en) Gelatin composition
GB8626276D0 (en) Magnesium alloy

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920908